Literature DB >> 20071760

Kinetic filtering of [(18)F]Fluorothymidine in positron emission tomography studies.

Katherine R Gray1, Kaiyumars B Contractor, Laura M Kenny, Adil Al-Nahhas, Sami Shousha, Justin Stebbing, Harpreet S Wasan, R Charles Coombes, Eric O Aboagye, Federico E Turkheimer, Lula Rosso.   

Abstract

[(18)F]Fluorothymidine (FLT) is a cell proliferation marker that undergoes predominantly hepatic metabolism and therefore shows a high level of accumulation in the liver, as well as in rapidly proliferating tumours. Furthermore, the tracer's uptake is substantial in other organs including the heart. We present a nonlinear kinetic filtering technique which enhances the visualization of tumours imaged with FLT positron emission tomography (FLT-PET). A classification algorithm to isolate cancerous tissue from healthy organs was developed and validated using 29 scan data from patients with locally advanced or metastatic breast cancer. A large reduction in signal from the liver and heart of 80% was observed following application of the kinetic filter, whilst the majority of signal from both primary tumours and metastases was retained. A scan acquisition time of 60 min has been shown to be sufficient to obtain the necessary kinetic data. The algorithm extends utility of FLT-PET imaging in oncology research.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20071760     DOI: 10.1088/0031-9155/55/3/010

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  12 in total

Review 1.  Development of radiotracers for oncology--the interface with pharmacology.

Authors:  Rohini Sharma; Eric Aboagye
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

2.  A Phase II Study of 3'-Deoxy-3'-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688.

Authors:  Lale Kostakoglu; Fenghai Duan; Michael O Idowu; Paul R Jolles; Harry D Bear; Mark Muzi; Jean Cormack; John P Muzi; Daniel A Pryma; Jennifer M Specht; Linda Hovanessian-Larsen; John Miliziano; Sharon Mallett; Anthony F Shields; David A Mankoff
Journal:  J Nucl Med       Date:  2015-09-10       Impact factor: 10.057

Review 3.  Importance of quantification for the analysis of PET data in oncology: review of current methods and trends for the future.

Authors:  Giampaolo Tomasi; Federico Turkheimer; Eric Aboagye
Journal:  Mol Imaging Biol       Date:  2012-04       Impact factor: 3.488

Review 4.  Functional imaging of hepatocellular carcinoma.

Authors:  Tim Ch Hoogenboom; Mark Thursz; Eric O Aboagye; Rohini Sharma
Journal:  Hepat Oncol       Date:  2016-03-29

5.  3'-Deoxy-3'-¹⁸F-fluorothymidine positron emission tomography as an early predictor of disease progression in patients with advanced and metastatic pancreatic cancer.

Authors:  Amarnath Challapalli; Tara Barwick; Rachel A Pearson; Shairoz Merchant; Francesco Mauri; Elizabeth C Howell; Katherine Sumpter; Ross J Maxwell; Eric O Aboagye; Rohini Sharma
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-02-12       Impact factor: 9.236

6.  Methodological considerations in quantification of 3'-deoxy-3'-[18F]fluorothymidine uptake measured with positron emission tomography in patients with non-small cell lung cancer.

Authors:  Virginie Frings; Adrianus J de Langen; Maqsood Yaqub; Robert C Schuit; Astrid A M van der Veldt; Otto S Hoekstra; Egbert F Smit; Ronald Boellaard
Journal:  Mol Imaging Biol       Date:  2014-02       Impact factor: 3.488

7.  Quantification of receptor-ligand binding with [¹⁸F]fluciclatide in metastatic breast cancer patients.

Authors:  Giampaolo Tomasi; Laura Kenny; Francesco Mauri; Federico Turkheimer; Eric O Aboagye
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-03       Impact factor: 9.236

8.  Metabolically active tumour volume segmentation from dynamic [(18)F]FLT PET studies in non-small cell lung cancer.

Authors:  Lieke L Hoyng; Virginie Frings; Otto S Hoekstra; Laura M Kenny; Eric O Aboagye; Ronald Boellaard
Journal:  EJNMMI Res       Date:  2015-04-23       Impact factor: 3.138

9.  Evaluation of 18F-fluorothymidine positron emission tomography ([18F]FLT-PET/CT) methodology in assessing early response to chemotherapy in patients with gastro-oesophageal cancer.

Authors:  R Sharma; P Mapelli; G B Hanna; R Goldin; D Power; A Al-Nahhas; S Merchant; R Ramaswami; A Challapalli; T Barwick; E O Aboagye
Journal:  EJNMMI Res       Date:  2016-11-16       Impact factor: 3.138

10.  Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[(11)C]PK11195 brain PET studies.

Authors:  Maqsood Yaqub; Bart N M van Berckel; Alie Schuitemaker; Rainer Hinz; Federico E Turkheimer; Giampaolo Tomasi; Adriaan A Lammertsma; Ronald Boellaard
Journal:  J Cereb Blood Flow Metab       Date:  2012-05-16       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.